Compared with normal lung tissues, the lung tissues of COVID-19 patients display complement system hyperactivation, characterized by extensive deposition of C3, C3b/iC3b/C3d, and C5b-9 and the increased expression of the complement regulatory proteins CD55 and CD59 (62). The gene discussed is C3; the disease is COVID-19.